吲哚美辛-丙磺舒相互作用的临床意义。
The clinical significance of indomethacin-probenecid interaction.
机构信息
Centre for Theumatic Diseases and University Department of Medicine, Royal Infirmary, Glasgow.
出版信息
Br J Clin Pharmacol. 1974 Aug;1(4):287-90. doi: 10.1111/j.1365-2125.1974.tb00254.x.
Abstract
1 The effect of the addition of probenecid to oral and rectal regimes of indomethacin was studied in three groups of rheumatoid arthritic patients. 2 The addition of probenecid increases plasma levels of indomethacin given both orally and rectally and significantly reduces the clinical parameters of joint inflammation. 3 The use of probenecid with indomethacin at night may be useful in reducing morning stiffness and pain. 4 Though indomethacin plasma levels are markedly raised during concurrent probenecid therapy remarkably few side effects were observed.
摘要
在三组类风湿关节炎患者中，研究了丙磺舒添加到吲哚美辛口服和直肠给药方案中的效果。
丙磺舒的添加增加了口服和直肠给予的吲哚美辛的血浆水平，并显著降低了关节炎症的临床参数。
吲哚美辛与丙磺舒在夜间联合使用可能有助于减少晨僵和疼痛。
尽管在同时使用丙磺舒治疗期间吲哚美辛的血浆水平显著升高，但观察到的不良反应很少。
相似文献
1
The clinical significance of indomethacin-probenecid interaction.
Br J Clin Pharmacol. 1974 Aug;1(4):287-90. doi: 10.1111/j.1365-2125.1974.tb00254.x.
2
An observer-blind crossover study to compare the efficacies of flurbiprofen, indomethacin and naproxen given orally and rectally in the relief of night pain and morning stiffness due to rheumatoid arthritis.
J Int Med Res. 1988 May-Jun;16(3):189-96. doi: 10.1177/030006058801600304.
3
The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study.
Clin Pharmacol Ther. 1978 Sep;24(3):298-307. doi: 10.1002/cpt1978243298.
4
Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate.
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):199-207. doi: 10.1007/BF00614018.
5
The effects of probenecid upon the individual components of indomethacin elimination.
J Pharmacol Exp Ther. 1977 May;201(2):463-70.
6
Clinical Pharmacokinetics of indomethacin.
Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58. doi: 10.2165/00003088-198106040-00001.
7
Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment.
Pharm World Sci. 1994 Feb 18;16(1):22-6. doi: 10.1007/BF01870935.
8
A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening.
Curr Med Res Opin. 1993;13(3):127-32. doi: 10.1185/03007999309111541.
9
The effects of differing pharmaceutical preparations of indomethacin on night pain and morning stiffness in patients with rheumatoid arthritis.
Curr Med Res Opin. 1987;10(9):592-5. doi: 10.1185/03007998709112412.
10
The effect of frusemide on indomethacin plasma levels.
Br J Clin Pharmacol. 1974 Dec;1(6):485-9. doi: 10.1111/j.1365-2125.1974.tb01698.x.
引用本文的文献
1
Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.
Drug Saf. 1993 Feb;8(2):99-127. doi: 10.2165/00002018-199308020-00002.
2
Clinical Pharmacokinetics of indomethacin.
Clin Pharmacokinet. 1981 Jul-Aug;6(4):245-58. doi: 10.2165/00003088-198106040-00001.
3
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
4
Correlation plasma levels, NSAID and therapeutic response.
Clin Rheumatol. 1985 Jun;4(2):124-32. doi: 10.1007/BF02032282.
5
The problems and pitfalls of NSAID therapy in the elderly (Part II).
Drugs Aging. 1991 May;1(3):212-27. doi: 10.2165/00002512-199101030-00005.
6
Drug interactions and clinical pharmacokinetics.
Clin Pharmacokinet. 1976;1(5):351-72. doi: 10.2165/00003088-197601050-00003.
7
The comparative gastric ulcerogenic activities of non-steroid anti-inflammatory drugs.
Agents Actions. 1977 Dec;7(5-6):573-7. doi: 10.1007/BF02111132.
本文引用的文献
1
208.--INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT.
Practitioner. 1965 Apr;194:560-5.
2
THE METABOLITES OF INDOMETHACIN, A NEW ANTI-INFLAMMATORY DRUG.
J Pharmacol Exp Ther. 1964 Feb;143:215-20.
3
DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.
Ann Rheum Dis. 1959 Mar;18(1):49-51; French transl 51-2; Spanish transl 52-3.
4
The renal excretion of indomethacin and its inhibition by probenecid.
Clin Pharmacol Ther. 1968 Jan-Feb;9(1):89-93. doi: 10.1002/cpt19689189.
5
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.
Q J Med. 1968 Jul;37(147):393-406.
6
Editorial: Pharmacokinetics--master or servant?
Eur J Clin Pharmacol. 1973 Jun;6(1):1-2. doi: 10.1007/BF00561792.
7
Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid.
Ann Rheum Dis. 1973 Sep;32(5):433-5. doi: 10.1136/ard.32.5.433.
8
An assessment of grip strength measurement in rheumatoid arthritis.
Scand J Rheumatol. 1974;3(1):17-23. doi: 10.3109/03009747409165124.
9
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis.
Br Med J. 1973 Jun 23;2(5868):685-8. doi: 10.1136/bmj.2.5868.685.
10
The metabolism of indomethacin in man.
J Pharmacol Exp Ther. 1972 Jun;181(3):563-75.
Zotero 插件